“Imatinib Treatment and Pharmacogenotype CYP3A4 in Relation With the Clonal Expansion Ph(+) in Chronic Myeloid Leukemia (CML)”. Colombia Medica, vol. 39, no. 4, Dec. 2008, pp. 314-22, https://doi.org/10.25100/cm.v39i4.613.